Brief: Aker Biomarine Q3 Adj. EBITDA Up At $19 Mln

Aker Biomarine ASA

01/11/2022 06:20

Nov 1 (Reuters) - Aker Biomarine ASA  AKBM.OL :
    * REVENUES OF USD 68 MILLION AND ADJUSTED EBITDA OF USD 19 MILLION FOR Q3 2022
    * Q3 ADJUSTED EBITDA OF USD 19 MILLION, UP FROM USD 15 MILLION SAME QUARTER LAST YEAR
    * FOR 2022, AKER BIOMARINE TARGETS REVENUE GROWTH OF 8%-12%, WITH AN ADJUSTED. EBITDA MARGIN
OF
23-26%
    * EXPECTS A LOWER REVENUE GROWTH AND AT SAME TIME HIGHER MARGINS THAN PREVIOUSLY TARGETED,
WHICH
IMPLIES AN UNCHANGED TARGETED ADJUSTED. EBITDA

Source text for Eikon:  ID:nObi7zFhva 
Further company coverage:  AKBM.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))